Chenghai Zhang

Title: **Chenghai Zhang: Innovator in Antibody Development**

Introduction

Chenghai Zhang is a prominent inventor based in Shanghai, China, recognized for his significant contributions to the field of biotechnology with a focus on antibody development. With a portfolio that includes four patents, Zhang's work is pivotal in advancing solutions for various medical conditions.

Latest Patents

Among his latest patents, Zhang developed an Anti-human MASP-2 antibody, which can specifically bind to human MASP-2. This invention includes a preparation method and application, showcasing its ability to inhibit the cleavage of C4 and the generation of C3b. This antibody is poised to be valuable in treating MASP-2 related diseases such as IgA nephropathy.

Additionally, he holds a patent for an Anti-human interleukin-4 receptor alpha antibody. This invention can bind to the human interleukin 4 receptor alpha (hIL-4R alpha) and has demonstrated effectiveness in inhibiting IL-4 and IL-13-induced cell line proliferation. Its applications are significant in addressing immune-mediated inflammatory diseases.

Career Highlights

Chenghai Zhang has worked for reputable companies in the biotechnology and pharmaceutical sectors. Notably, he has contributed his expertise at Shanghai Mabgeek Biotech Co., Ltd and Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. His innovative approach to antibody development has positioned him as a key player in these organizations.

Collaborations

Throughout his career, Zhang has collaborated with esteemed professionals, including Jinlin Guo and Wei Dang. These partnerships have facilitated knowledge exchange and fostered advancements in research and development.

Conclusion

Chenghai Zhang stands out as an influential inventor in the biotechnology field. His innovative antibody therapies contribute to the ongoing fight against various diseases, reinforcing the importance of research and invention in improving human health.